Cite
HARVARD Citation
Reinisch, W. et al. (n.d.). S3200 ABP 710, a Biosimilar to Infliximab Reference Product: Supporting Extrapolation of Indications With a Focus on Crohn's Disease. American journal of gastroenterology. pp. S1678-S1679. [Online].